Acro Biomedical (ACBM) Non Operating Income (2018 - 2023)

Acro Biomedical has reported Non Operating Income for 6 years, with the latest figure at $789.0 in Q2 2023.

• For the quarter ending Q2 2023, Non Operating Income rose 273.93% year-over-year to $789.0; the trailing twelve-month figure through Jun 2023 stood at $2863.0 (up 257.88% YoY), and the FY2025 full-year result was $52878.0, up 1318.67% from the prior year.
• Non Operating Income for Q2 2023 stood at $789.0, roughly flat from $788.0 in the prior quarter.
• The five-year high for Non Operating Income was $2503.0 in Q1 2021, with the low at -$826.0 in Q3 2019.
• Average Non Operating Income over 5 years is $446.76, with a median of $211.0 recorded in 2022.
• Year-over-year, Non Operating Income tumbled 308.33% in 2020 and jumped 667.57% in 2021.
• Tracing ACBM's Non Operating Income over 5 years: stood at -$440.0 in 2019, then soared by 454.09% to $1558.0 in 2020, then sank by 87.03% to $202.0 in 2021, then jumped by 289.6% to $787.0 in 2022, then climbed by 0.25% to $789.0 in 2023.
• The last three Non Operating Income figures came in at $789.0 (Q2 2023), $788.0 (Q1 2023), and $787.0 (Q4 2022), per Business Quant data.

Peer Comparison